Dorte Vistisen
Steno Diabetes Center
157 Papers
399 Citations
Dorte Vistisen is an academic researcher from Steno Diabetes Center. The author has contributed to research in topics: Diabetes mellitus & Medicine. The author has an hindex of 30, co-authored 120 publications. Previous affiliations of Dorte Vistisen include Novo Nordisk & University of Southern Denmark.
Chat about Author
Papers
Moving to an HbA1c based diagnosis of diabetes has a different impact on prevalence in different ethnic groups Running title: Diabetes prevalence and diagnostic tools
Dirk L. Christensen,Daniel R. Witte,Lydia Kaduka,Knut Borch-Johnsen,Viswanathan Mohan,Jonathan E. Shaw,Adam G. Tabak,Dorte Vistisen +7 more
- 01 Jan 2009
TL;DR: Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark Steno Diabetes Center A/S, Gentofte, Denmark Centre for Public Health Research, KEMRI, Nairobi, Kenya.
6
Intensive multifactorial treatment modifies the effect of family history of diabetes on glycaemic control in people with Type 2 diabetes: a post hoc analysis of the ADDITION-Denmark randomized controlled trial
Galal M. Eliraqi,Galal M. Eliraqi,Dorte Vistisen,Torsten Lauritzen,A. Sandbaek,Marit E. Jørgensen,Kristine Færch +6 more
TL;DR: To investigate whether intensive multifactorial treatment can reverse the predisposed adverse phenotype of people with Type 2 diabetes who have a family history of diabetes, a large number of subjects have been diagnosed with type 2 diabetes and the prognosis is poor.
6
Comment on: Tam et al. Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps. Diabetes Care 2012;35:1605–1610
Kristine Færch,Dorte Vistisen +1 more
TL;DR: The authors’ effort to translate detailed phenotypic data into clinical usefulness is appreciated, but defining a cutoff point is always challenging, and the study raises a number of questions.
6
Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial
Jonas Salling Quist,Hanne Pedersen,Marie Møller Jensen,Kim K. B. Clemmensen,Natasja Bjerre,T. S. Ekblond,Sarah Uldal,Joachim Størling,Nicolai J Wewer Albrechtsen,Jens Juul Holst,Signe S. Torekov,Martin Erik Nyeland,Dorte Vistisen,M. E. Jørgensen,Satchidananda Panda,Christina Brock,Graham Finlayson,Martin B. Blond,Kristine Færch +18 more
TL;DR: 3 months of 10-h per-day time-restricted eating did not lead to clinically relevant effects on bodyweight in middle-aged to older individuals at high risk of type 2 diabetes.
6
Declining Incidence Rates of Distal Symmetric Polyneuropathy in People With Type 1 and Type 2 Diabetes in Denmark, With Indications of Distinct Patterns in Type 1 Diabetes.
H. I. Mizrak,Tine W. Hansen,Peter Rossing,Viktor Rotbain Curovic,Dorte Vistisen,Hanan Amadid,Christian Stevns Hansen +6 more
TL;DR: This Danish study (1996-2018) found declining incidence rates of diabetic distal symmetric polyneuropathy (DSPN) in type 1 and type 2 diabetes, with distinct age-related patterns suggesting differing pathophysiology between diabetes types, possibly due to improved treatment.
6